Discharge counseling for patients with heart failure or myocardial infarction: A best practices model developed by members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network based on the Hospital to Home (H2H) initiative

Pharmacotherapy

Volumn 33, Issue 5, 2013, Pages 558-580

  Wiggins, Barbara S ^a   Rodgers, Jo E ^b   DiDomenico, Robert J ^d   Cook, Abigail M ^e   Page II, Robert L ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Counseling; Discharge; Heart failure; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DRONEDARONE; EPLERENONE; FLUINDOSTATIN; GEMFIBROZIL; GLYCERYL TRINITRATE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; ISOSORBIDE; MEVINOLIN; NICOTINIC ACID; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PSEUDOEPHEDRINE; RANOLAZINE; SIMVASTATIN; UNINDEXED DRUG; VERAPAMIL;

ANGINA PECTORIS; ANGIONEUROTIC EDEMA; CAREGIVER; CLINICAL PRACTICE; COMORBIDITY; COUGHING; DIET; DIZZINESS; DRUG CONTRAINDICATION; DRUG INDUCED HEADACHE; ENVIRONMENTAL FACTOR; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH EDUCATION; HEALTH INSURANCE; HEART FAILURE; HEART INFARCTION; HOSPITAL CARE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; IMMUNIZATION; INTERDISCIPLINARY COMMUNICATION; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; MEDICATION COMPLIANCE; MEDICATION ERROR; MEDICATION THERAPY MANAGEMENT; OUTPATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT REFERRAL; PHARMACIST; PRACTICE GUIDELINE; REVIEW; SELF CARE; SEXUAL DYSFUNCTION; SYSTOLIC DYSFUNCTION;

DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HEART FAILURE; HUMANS; MEDICATION ADHERENCE; MEDICATION RECONCILIATION; MODELS, ORGANIZATIONAL; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PATIENT EDUCATION AS TOPIC; PATIENT READMISSION; PHARMACEUTICAL SERVICES; SOCIETIES, PHARMACEUTICAL; UNITED STATES;

EID: 84879570770     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1231     Document Type: Review

References (96)

1. Koelling TM, Johnson ML, Cody RJ, Aaronson DK. Clinical outcomes in patients with heart failure. Circulation 2005;111:179-185.
2. Riegel B, Carlson B, Glaser D, Hoagland P. Which patients with heart failure respond best to multidisciplinary disease management? J Card Fail 2000;6:290-299.
3. Saab PG, Bang H, Williams RB, et al. The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience. J Phychosom Res 2009;67:45-56.
4. Oterhals K, Hanestad BR, Eide GE, Hanssen TA. The relationship between in-hospital information and patient satisfaction after acute myocardial infarction. Eur J Cardiovasc Nurs 2006;5:303-310.
5. Sanderson BK, Thompson J, Brown TM, Tucker MJ, Bittner V. Assessing patient recall of discharge instructions for acute myocardial infarction. J Healthc Qual 2009;31:25-33; quiz 34.
6. Ni H, Nauman D, Burgess D, Wise K, Crispell K, Hershberger RE. Factors influencing knowledge of and adherence to selfcare among patients with heart failure. Arch Intern Med 1999;159:1613-1619.
7. Stewart S, Pearson S. Uncovering a multitude of sins: medication management in the home post acute hospitalisation among the chronically ill. Aust NZ J Med 1999;29:220-227.
8. Alibhai SM, Han RK, Naglie G. Medication education of acutely hospitalized older patients. J Gen Intern Med 1999;14:610-616.
9. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the Guideline for the Management of Patients With Unstable Angina/Non -ST-Elevation Myocardial Infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2012;126:875-910.
10. Lidenfield J, Albert NM, Boehmer JP, et al. Section 6: nonpharmacologic management and health care maintenance in patients with chronic heart failure. J Card Fail 2010;16:e61-e72.
11. Moser DK, Doering LV, Chung MK. Vulnerabilities of patients recovering from an exacerbation of chronic heart failure. Eur J Cardiovasc Nurs 2005;4:90.
12. Cacciatore F, Abete P, Ferrara N, et al. Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc 1998;46:1343-1348.
13. Zuccala G, Onder G, Pedone C, et al. Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicentre survey. On behalf of the GIFA (SIGG-ONLUS) Investigators. J Neurol Neurosurg Psychiatry 2001;70:109-112.
14. Zuccala G, Pedone C, Cesari M, et al. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 2003;115:97-103.
15. Faris R, Purcell H, Henein MY, Coats AJ. Clinical depression is common and significantl associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail 2002;4:541-551.
16. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001;161:1849-1856.
17. Joynt KE, Whellan DJ, O'Connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail 2004;10:258-271. 35.
18. Martensson J, Dracup K, Canary C, Fridlund B. Living with heart failure: depression and quality of life in patients and spouses. J Heart Lung Transplant 2003;22:460-467.
19. Lindenfeld J, et al. Section 8: disease management in heart failure education and counseling. J Card Fail 2006;12:e58-e69.
20. Serxner S, Miyaji M, Jeffords J. Congestive heart failure disease management study: a patient education intervention. Congest Heart Fail 1998;4:23-28.
21. Fulmer TT, Feldman PH, Kim TS, et al. An intervention study to enhance medication compliance in community-dwelling elderly individuals. J Gerontol Nurs 1999;25:6-14.
22. Stromberg A, Ahlen H, Fridlund B, Dahlstrom U. Interactive education on CD-ROM-a new tool in the education of heart failure patients. Patient Educ Couns 2002;46:75-81.
23. Riegel B, Carlson B, Glaser D. Development and testing of a clinical tool measuring self-management of heart failure. Heart Lung 2000;29:4-15.
24. Grady KL, Dracup K, Kennedy G, et al. Team management of patients with heart failure: a statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation 2000;102:2443-2456.
25. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997;30:725-732.
26. Moser DK. Heart failure management: optimal health care delivery programs. Annu Rev Nurs Res 2000;18:91-126.
27. Horowitz CR, Rein SB, Leventhal H. A story of maladies, misconceptions and mishaps: effective management of heart failure. Soc Sci Med 2004;58:631-643.
28. Schillinger D, Piette J, Grumbach K, et al. Physician communication with diabetic patients who have low health literacy. Arch Intern Med 2003;163:83-90.
29. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 2007;298:49-60.
30. Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of Medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm 2008;14:553-560.
31. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care 2004;42:102-109.
32. Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH. Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation 2008;117:1261-1268.
33. Chernew ME, Shah MR, Wegh A, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood) 2008;27:103- 112.
34. Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventative medications after myocardial infarction. NEJM 2011;365:2088-2097.
35. Moser DK, Mann DL. Improving outcomes in heart failure: it's not unusual beyond usual care. Circulation 2002;105:2810-2812.
36. Bernard S. Disease management: a pharmaceutical industry perspective. Pharmaceutical Exec 1995;16:48-50.
37. Carter BL, Farris KB, Abramowitz PW, et al. The Iowa continuity of care study: background and methods. Am J Health- Syst Pharm 2008;65:1631-1642.
38. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006;166:565-571.
39. Cabezas CL, Salvador CF, Quadrada DC, et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. Farm Hops 2006;30:328-342.
40. Eggink RN, Lenderlink AW, Widdershoven JW, Van den Bemt PM. The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure. Pharm World Sci 2010;32:759-766.
41. Gwadry-Sridhar FH, Arnold JMO, Zhang Y, Brown JE, Marchiori G, Guyatt G. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J 2005;150:e982.e1-e982.e9
42. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:529-555.
43. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:e78-e140.
44. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-STelevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. Circulation 2008;118:2596-2648.
45. Specifications manual for national hospital inpatient quality measures. Centers for Medicare and Medicaid Services and The Joint Commission, Version 3.2c, Effective discharges Available from http://www.jointcommission.org/ specifications-manual-for-national-hospital-inpatient-quality-measures/. Accessed October 1, 2010.
46. Specifications manual for national hospital inpatient quality measures. Centers for Medicare and Medicaid Services The Joint Commission, 2010.
47. Grundy SM, Becker D, Clark LT, et al. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-2497.
48. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008;31(Suppl 1):S12-S54.
49. Becker RC, Meade TW, Berger PB, et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:776S-7814S.
50. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
51. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-239.
52. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;54:2205-2241.
53. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309- 1321.
54. Lappe JM, Muhlestein JB, Lappe DL, et al. Improvements in 1-year cardiovascular clinical outcomes associated with a hospital- based discharge medication program. Ann Intern Med 2004;141:446-453.
55. Naylor M, Brooten D, Jones R, et al. Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial. Ann Intern Med 1994;120:999-1006.
56. Krumholz HM, Baker DW, Ashton CM, et al. Evaluating quality of care for patients with heart failure. Circulation 2000;101:e122-e140.
57. Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes. Circulation 2007;116:737-744.
58. Phillips CO, Wright SM, Kern DE, et al. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA 2004;291:1358-1367.
59. Koelling TM, Johnson ML, Cody RJ, et al. Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation 2005;111:179-185.
60. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53: e1-e90.
61. Bonow RO, Bennett S, Casey DE Jr, et al. ACC/AHA Clinical Performance Measrues for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation 2005;112:1853-87. Epub 2005 Sep 13.
62. Pfizer. Nitrostat® (nitroglycerin tablets USP) prescribing information. New York, NY: Pfizer; 2005.
63. Novartis Pharmaceutical Corporation. Lescol® (fluvastain sodium) capsules & Lescol XL® (fluvastatin sodium) extended release tablets prescribing information. East Hanover, NJ: Novartis Pharmaceutical Corporation; 2006.
64. Merck & Co., Inc. Mevacor® (lovastatin) prescribing information. Whitehouse Station, NJ: Merck & Co., Inc.; 2010.
65. Merck & Co., Inc. Zocor (simvastatin) prescribing information. Whitehouse Station, NJ: Merck & Co., Inc.; 2010.
66. Plakogiannis R, Cohen H. Optimal low-density lipoprotein cholesterol lowering-morning versus evening statin administration. Ann Pharmacother 2007;41:106-110.
67. Abbott Laboratories. Niaspan® tablets (niacin extended release) prescribing information. North Chicago, IL: Abbott Laboratories; 2010.
68. Chow SL, Singh H, DiDomenico RJ, et al. Key articles related to complementary and alternative medicine in cardiovascular disease: part II. Pharmacotherapy 2011;31:208e-277e.
69. Hudson M, Richard H, Pilote L. Differences in outcomes of patients with congestive heart failure prescribed celecoxib, ro-fecoxib, or nonsteroidal anti-inflammatory drugs: population based study. BMJ 2005;330:1370.
70. Mamdani M, Juurlink DN, Lee DS, et al. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 2004;363:1751e6.
71. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842-1847.
72. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 2008;117:1028-1036.
73. Wu JR, Moser DK, Chung ML, Lennie TA. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Cardiac Fail 2008;14:203-210.
74. Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L, Mangues MA. Bayes-genis a negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist multidisciplinary HF clinc. J Cardiac Failure 2011;17:217-223.
75. van der Wal MH, Jaarsma T, van Veldhuisen DJ. Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Fail 2005;7:5-17.
76. Van der Wal MHL, Jaarsma T. Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol 2008;125:203-208.
77. Dunlay SM, Eveleth JM, Shah ND, McNallan SM, Roger VL. Medication adherence among community-dwelling patients with heart failure. Mayo Clin Proc 2011;86:273-281.
78. Target Pharmacy® (March 2012) $4 and $10 Generic Medication List (sorted by disease). Available from http://tgtfiles.target.com/ pharmacy/WCMP02-030049-RxGenericsListNM11.pdf. Accessed April 9, 2012.
79. Walgreens Co. Walgreens Prescription Drug Savings Club, 2011, Available from http://www.walgreens.com/images/psc/pdf/Value-PricedGenericsList.pdf. Accessed April 9, 2012.
80. Wal-Mart Stores, Inc. Retail Prescription Drug Program Drug List. (Revised 10/19/11) Available from http://i.walmartimages.com/i/if/hmp/fusion/ customer-list.pdf. Accessed April 9, 2012.
81. CVS Pharmacy Health Savings Pass Medication List April 2012. Available from https://www.cvs.com/CVSApp/cvscontent/landingpages/rx/rx11001-hsp/ HSP%20Medication%20List%20Update%20April%202012.pdf. Accessed April 9, 2012.
82. Zannad F, McMurray JV, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364:11-21.
83. Moser DK. Heart failure management: optimal health care delivery programs. Annu Rev Nurs Res 2000;18:91-126.
84. Houston TK, Allison JJ, Person S, Kovac S, Williams OD, Kiefe CI. Post-myocardial infarction smoking cessation counseling: associations with immediate and late mortality in older Medicare patients. Am J Med 2005;118:269-275.
85. Smith PM, Burgess E. Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial. CMAJ 2009;180:1297-1303.
86. Van Spall HG, Chong A, Tu JV. Inpatient smoking-cessation counseling and all-cause mortality in patients with acute myocardial infarction. Am Heart J 2007;154:213-220.
87. Shah DD, Fonarow GC, Horwich TB. Metformin therapy and outcomes in patients with advancedsystolic heart failure and diabetes. J Card Fail 2010;16:200-206.
88. Nesto RW, Bell D, Bonow RO, et al. AHA/ADA consensus statement. Thiozolidinedione use, fluid retention, and congestive heart failure. A consensus statement from the American Heart Association and American Diabetes Association. Circulation 2003;108:2941-2948.
89. Cilostazol prescribing information. Teva Pharmaceuticals USA. Sellersville, PA 18960. 06/2010
90. Kober L, Torp-Pedersen C, McMurray J, et al. Increased mortality after dronederone therapy for severe heart failure. N Engl J Med 2008;358:2678-2687.
91. Gibbs CR, Jackson G, Lip GY. ABC of heart failure. Non-drug management. BMJ 2000;320:366e9.
92. Witte KK, Clark AL. Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives. Heart Fail Rev 2006;11:65e74.
93. Happ MB, Naylor MD, Roe-Prior P. Factors contributing to rehospitalization of elderly patients with heart failure. J Cardiovasc Nurs 1997;11:75-84.
94. Bennett SJ, Milgrom LB, Champion V, Huster GA. Beliefs about medication and dietary compliance in people with heart failure: an instrument development study. Heart Lung 1997;26:273-279.
95. Bentley B, DeJong MJ, Moser DK, Peden A. Factors related to nonadherence to a low sodium diet in patients with heart failure. Eur J Cardiovasc Nurs 2005;4:331-336.
96. Smith SC, Allen J, Blair SN, Bonow RO, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the national heart, lung, and blood institute. Circulation 2006;113:2363-2372.